Mindset Pharma, Inc.

Otsuka Pharmaceutical Co. Ltd. is paying up to $1.3bn for private US-based drug discovery specialist Jnana Therapeutics Inc. , in a deal that will give the Japanese major access to platform technolo

The US FDA will face some crucial tests for its nascent approach to regulation of psychedelic drug candidates in the coming year, headlined by an 11 August 2024 user fee goal for the first psychedelic

Otsuka Pharmaceutical Co. Ltd. has teamed up Seattle, US-based biotech Shape Therapeutics, Inc. (ShapeTX) to further expand its R&D capabilities related to gene therapies for eye disorders. The up

Otsuka Pharmaceutical Co. Ltd. is set to expand its neurological pipeline through the acquisition of Canadian firm Mindset Pharma, Inc. CAD8m ($6m). Since 2022, the Toronto-based firm has been coll